Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease. (ACESO-IHD)
Clinical trial NCT04776239 · COMPLETED
Trial details
- NCT number
- NCT04776239
- Sponsor
- Joshua M Hare
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-16
- Primary completion
- 2025-03-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.